Axsome Therapeutics, Inc. Income Statement
AXSM / Health Care|12 years of annual SEC 10-K data (FY2014-FY2025)
Line items include revenue, cost of goods sold, gross profit, operating expenses, interest, taxes, and net income with per-share data across 12 fiscal years. All figures from audited SEC 10-K filings.
Axsome Therapeutics, Inc. reported $638M in revenue and $183M in net loss for FY2025. Revenue has grown at a 53.6% compound annual rate over the past 2 years.
Based on SEC 10-K filings.
Key Data Points
- Altman Z-Score -1.15 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
| Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $638.5M | $385.7M | $270.6M | $0 | - | - | - | - | - | - | - | - |
| Cost of Revenue | - | - | - | $5.2M | - | - | - | - | - | - | - | - |
| SG&A Expense | $570.6M | $411.4M | $323.1M | $159.3M | $66.6M | $28.9M | $13.6M | $9.4M | $7.2M | $6.3M | $2.4M | $1.4M |
| R&D Expense | $183.3M | $187.1M | $97.9M | $57.9M | $58.1M | $70.2M | $53.6M | $23.5M | $20.0M | $21.2M | $6.8M | $4.3M |
| Operating Income | -$166.8M | -$280.6M | -$231.8M | -$179.8M | -$124.7M | -$99.1M | -$67.2M | -$32.8M | -$27.2M | -$27.5M | -$9.2M | -$5.7M |
| Interest Expense | -$15.9M | -$21.6M | -$20.0M | -$9.7M | - | - | - | - | - | - | - | - |
| Income Tax | -$530.0K | $85.0K | $960.0K | $0 | $0 | $0 | $0 | $0 | $0 | $0 | - | - |
| Net Income | -$183.2M | -$287.2M | -$239.2M | -$187.1M | -$130.4M | -$102.9M | -$68.3M | -$31.0M | -$28.9M | -$27.2M | -$12.2M | -$6.0M |
| EPS (Basic) | -$3.68 | -$5.99 | -$3.47 | -$2.77 | -$3.47 | -$2.77 | - | - | - | - | - | - |
| EPS (Diluted) | -$3.68 | -$5.99 | -$3.47 | -$2.77 | -$3.47 | -$2.77 | - | - | - | - | - | - |
| Shares Outstanding | 50.9M | 48.7M | 43.5M | 37.8M | 37.6M | 37.2M | 34.0M | 26.9M | 22.8M | 19.2M | 11.9M | 9.1M |
| Operating Margin | -26.1% | -72.7% | -85.7% | - | - | - | - | - | - | - | - | - |
| Profit Margin | -28.7% | -74.5% | -88.4% | - | - | - | - | - | - | - | - | - |